The following are some of today’s top gainers in the pharma/biotech sector.
1. Ra Medical Systems Inc. (RMED)
Ra Medical is a commercial-stage medical device company, with a focus on vascular and dermatological diseases.
Gained 32.43% to close Thursday’s (Aug.15) trading at $1.96.
News: No news
On August 13, 2019, the Company reported certain preliminary financial results for the quarter ended June 30, 2019, as well as a leadership transition.
Ra Medical expects revenue to be between $2.02 million and $2.2 million for the second quarter of 2019.
The Company also announced the termination of Dean Irwin from the posts of Chief Executive Officer, Co-President, and Chief Technology Officer, and as Chairman of its Board of Directors. Andrew Jackson, currently serving as Chief Financial Officer, has been appointed to serve as Interim Chief Executive Officer.
There is also going to be a delay in the reporting of earnings for the second quarter of 2019 and the filing of its Quarterly Report on Form 10-Q for the quarter ended June 30, 2019.
2. Sintx Technologies Inc. (SINT)
SINTX Technologies is a commercial biomaterial company focused on using its silicon nitride technology platform to develop, manufacture and sell a broad range of medical devices.
Gained 23.73% to close Thursday’s trading at $2.19.
News: The Company announced financial results for the second quarter ended June 30, 2019, and also revealed that it is now compliant with the minimum bid price requirement for continued listing on the Nasdaq Stock Market.
The revenue for the second quarter of 2019 was $0.2 million compared to nil revenue in the year-ago quarter. The loss from continuing operations for the recent second quarter was $0.73 million or $1.46 per share compared to a loss from continuing operations $2.181 million or $12.06 per share in the year-ago